Since, according to our best knowledge, our study is the first that analyzed PDCD1 and PD-L1 gene polymorphisms in the context of renal cell cancer, further studies will be needed in order to determine whether rs7421861T>C polymorphism may be considered to be a risk factor for this type of cancer. This evidence concerns the gene CD274 and renal cell adenocarcinoma.